Arkadiusz Wyrzucki

Arkadiusz Wyrzucki has a strong background in scientific research and development. Arkadiusz began their career with an internship at Okairos, S.R.L., where they gained extensive knowledge about gene therapy and vaccine design. Arkadiusz also learned about evaluating drugs in clinical trials and providing legal protection.

After their internship, Wyrzucki worked at the Institute of Medical Virology University of Zurich as a Research Scientist. Arkadiusz'sresearch focused on antibody engineering and recombinant vaccine design. Arkadiusz collaborated with colleagues to submit scientific publications, finalize patent procedures, and find industrial partners for further development of their antibodies and vaccines.

Following their time at the Institute, Wyrzucki joined Humabs BioMed as a Scientist. Arkadiusz was responsible for the selection and optimization of therapeutic monoclonal antibodies against infectious diseases. During this role, they developed skills in phage display technology and learned a high-throughput platform for screening antibodies using immortalized B cells.

Most recently, Wyrzucki has been working at Celerion as a Senior Scientist. Details about their specific role and responsibilities are not provided, but they have been with the company since 2016.

Arkadiusz Wyrzucki earned their Bachelor of Science (BS) degree in Biotechnology from the University of Gdansk. Arkadiusz later pursued a Master of Science (MS) degree in Molecular Biology from the University of Chicago. Subsequently, they obtained their Doctor of Philosophy (PhD) in Virology from the University of Zurich.